01 4AstraZeneca Canada Inc.
01 12423279
02 12517629
03 12547077
04 12664275
01 4OLAPARIB
01 4CAPSULE
01 12021-10-25
02 12024-03-12
03 12024-11-30
04 12027-10-15
Patent Expiration Date : 2024-11-30
Date Granted : 2015-11-03
Brand Name : LYNPARZA
Patent Number : 2547077
Filing Date : 2004-11-30
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-11-30
Date Granted : 2015-11-03
Patent Expiration Date : 2027-10-15
Date Granted : 2015-03-17
Brand Name : LYNPARZA
Patent Number : 2664275
Filing Date : 2007-10-15
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-10-15
Date Granted : 2015-03-17
Patent Expiration Date : 2021-10-25
Date Granted : 2011-07-05
Brand Name : LYNPARZA
Patent Number : 2423279
Filing Date : 2001-10-25
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-10-25
Date Granted : 2011-07-05
Patent Expiration Date : 2024-03-12
Date Granted : 2011-07-12
Brand Name : LYNPARZA
Patent Number : 2517629
Filing Date : 2004-03-12
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-03-12
Date Granted : 2011-07-12
